Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2012
05/10/2012US20120115935 Anti-cancer agent, method for inducing apoptosis of cancer cells, and method for screening for anti-cancer agent
05/10/2012US20120115932 Modulation of stat 6 expression
05/10/2012US20120115929 Means And Methods For Counteracting, Preventing And/Or Determining Heart Failure, Or A Risk Of Heart Failure
05/10/2012US20120115924 Micro-RNA Mediated Modulation of Colony Stimulating Factors
05/10/2012US20120115923 Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment
05/10/2012US20120115922 Smac mimetec
05/10/2012US20120115896 Isogenic human cell lines comprising mutated cancer alleles and process using the cell lines
05/10/2012US20120115838 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same
05/10/2012US20120115797 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012US20120115795 Regulation of Sodium Channels by PLUNC Proteins
05/10/2012US20120115790 Therapeutic approach to neurodegenerative disorders using a tfp5-peptide
05/10/2012US20120115785 Endothelial nitric oxide synthase antagonists and uses thereof for inhibiting oxygen toxicity
05/10/2012US20120115775 Mutant tat proteins and uses thereof
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115234 Down-regulation of gene expression using artificial micrornas
05/10/2012US20120115233 Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof
05/10/2012US20120115232 Method for inducing degradation of protein in mammalian cell
05/10/2012US20120115231 Novel lysophospholipid acyltransferase
05/10/2012US20120115230 Phenylpropanoid related regulatory protein-regulatory region associations
05/10/2012US20120115229 Embryonic stem cells and neural progenitor cells derived therefrom
05/10/2012US20120115228 Oligomeric compounds and compositions for the use in modulation of micrornas
05/10/2012US20120115227 Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements
05/10/2012US20120115226 3D CULTURING SYSTEMS FOR GROWTH AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM (hPS) CELLS
05/10/2012US20120115225 Reprogramming of somatic cells with purified proteins
05/10/2012US20120115224 Culture methods of bone marrow stromal cells and mesenchymal stem cells, and manufacture method of graft cells for central nerve system diseases therapy
05/10/2012US20120115223 Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
05/10/2012US20120115222 Composition and method for maintenance, differentiation, and proliferation of stem cells
05/10/2012US20120115221 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
05/10/2012US20120115207 Enhanced production of papillomavirus-like particles with a modified baculovirus expression system
05/10/2012US20120115164 Mammalian cytokines; related reagents
05/10/2012US20120115161 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
05/10/2012US20120115156 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
05/10/2012US20120115134 Methods for diagnosis and prognosis of cancer
05/10/2012US20120114799 Polypeptides Having Phytase Activity and Polynucleotides Encoding Same
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114729 Silicone-peroxide compositions for long-term, controlled oxygen release
05/10/2012US20120114713 Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114704 Compounds, compositions and methods of treating cancer and fibrotic diseases
05/10/2012US20120114700 Lat adapter molecule for enhanced t-cell signaling and method of use
05/10/2012US20120114691 Vaccine against african horse sickness virus
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114683 Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
05/10/2012US20120114681 Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (mgus) or of smoldering multiple myeloma (smm)
05/10/2012US20120114680 Dendritic Cell Compositions and Methods
05/10/2012US20120114675 Foxp3+ natural killer t-cells and the treatment of immune related diseases
05/10/2012US20120114672 Antibodies Specific to Cadherin-17
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114657 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa
05/10/2012US20120114654 Human antibodies to human tnf-like ligand 1a (tl1a)
05/10/2012US20120114652 Anti-pai-1 antibodies and methods of use thereof
05/10/2012US20120114647 anti-serum album single variable domains
05/10/2012US20120114639 Compositions and methods for inhibiting viral and/or bacterial infections
05/10/2012US20120114630 Variants of plasminogen and plasmin
05/10/2012US20120114623 Antigen-specific long-term memory t-cells
05/10/2012US20120114620 Engineered Dendritic Cells and Uses for the Treatment of Cancer
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114618 Mesenchymal Stem Cells Producing Inhibitory RNA for Disease Modification
05/10/2012US20120114617 Peptide promoting cell adhesion and migration
05/10/2012US20120114616 Olfactory stem cells and uses thereof
05/10/2012US20120114614 Methods and compositions for long term hematopoietic repopulation
05/10/2012US20120114613 Definitive endoderm cell populations
05/10/2012US20120114605 Methods and compositions relating to hematologic malignancies
05/10/2012US20120114603 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities
05/10/2012US20120114597 Cd4+cd25- t cells and tr1-like regulatory t cells
05/10/2012US20120114593 Method and composition for altering a b cell mediated pathology
05/10/2012US20120111795 Differentiated human liver cell cultures and their use in bioartificial liver systems
05/10/2012DE102010043555A1 Ex-vivo culturing of tissues or embryonic organ systems on multiwell plate, comprises placing tissue or embryonic organ system at or near center of circular surface of well bottom, adding nutrient medium, and incubating
05/10/2012CA2821562A1 Method of producing intestinal cells
05/10/2012CA2816763A1 Markers of endothelial progenitor cells and uses thereof
05/10/2012CA2815426A1 Compositions and methods for the generation of platelets and methods of use thereof
05/10/2012CA2814704A1 Methods and vectors for cell immortalisation
05/09/2012EP2450707A1 Lung tissue model
05/09/2012EP2450447A1 Manipulation of plant senescence using modified promoters
05/09/2012EP2450435A1 Maltotriocil transferase, process for production thereof, and use thereof
05/09/2012EP2450433A2 Methods of preparing and using stem cell compositions and kits comprising the same
05/09/2012EP2450432A1 Materials composition and methods to control neural progenitor and stem cell attachment, proliferation and guide cell differentiation
05/09/2012EP2450431A1 Blood component separation system and separation material
05/09/2012EP2450430A1 Bioassay method for antibody against thyroid-stimulating hormone receptor, measurement kit for the antibody, and novel genetically modified cell for use in the bioassay method or the measurement kit
05/09/2012EP2450381A1 Anti-RHD monoclonal antibodies
05/09/2012EP2450379A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/09/2012EP2450378A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/09/2012EP2450377A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/09/2012EP2450376A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
05/09/2012EP2450375A1 Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
05/09/2012EP2450065A1 Corneal epithelium forming cell sheets, processes for producing the same, and methods of using the same
05/09/2012EP2450052A2 Dendritic cells
05/09/2012EP2449095A1 Method of producing erythrocytes without feeder cells
05/09/2012EP2449093A1 Unshrunken tissue equivalent, skin equivalent comprising such an unshrunken tissue equivalent, and methods for producing such an unshrunken tissue equivalent and such a skin equivalent
05/09/2012EP2448970A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
05/09/2012EP2448961A2 Targets for retrovirus associated diseases
05/09/2012EP2448958A1 Human milk peptides
05/09/2012EP2245150B1 Protease for wound conditioning and skin care
05/09/2012EP1740202B1 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
05/09/2012EP1711052B1 Mouse model for psoriasis and psoriatic arthritis
05/09/2012EP1496110B1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
05/09/2012EP1492813B1 OX40R binding agents
05/09/2012EP1427830B1 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 1827